Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement-Reference-Cited by-同舟云学术

Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement

Published:1999-04 Issue:4 Volume:33 Page:709-717
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Johannsson Gudmundur,Bengtsson Bengt-Åke,Ahlmén Jarl

Publisher

Elsevier BV

Subject

Nephrology

Reference41 articles.

1. Swedish Registry for Active Treatment of Uremia;Schön,1996

2. Importance of nutrition in dialysis patients;Blagg;Am J Kidney Dis,1991

3. Nutritional status of patients on hemodialysis and peritoneal dialysis;Marckman;Clin Nephrol,1988

4. Protein and amino acid metabolism in uremia: Influence of metabolic acidosis;Mitch;Kidney Int,1989

5. Role of parathyroid hormone in the glucose intolerance of chronic renal failure;Akmal;J Clin Invest,1985

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone in pediatric chronic kidney disease: more than just height;Pediatric Nephrology;2024-04-12

2. Growth hormone treatment in aged patients with comorbidities: A systematic review;Growth Hormone & IGF Research;2024-04

3. Pharmacologic therapeutics in sarcopenia with chronic kidney disease;Kidney Research and Clinical Practice;2024-03-31

4. The Effect of Non-Pharmacological and Pharmacological Interventions on Measures Associated with Sarcopenia in End-Stage Kidney Disease: A Systematic Review and Meta-Analysis;Nutrients;2022-04-27

5. Frailty in CKD and Transplantation;Kidney International Reports;2021-09